Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices – Market Insights – Latin America (Supplemental)

The COVID-19 pandemic had a short-term impact on the Latin American GI endoscopy device market because many screening and elective interventional procedures were deferred in 2020 as per safety guidelines. Following the impact, the market saw a subsequent recovery and will expand moderately through 2032 as the market observes innovation in diagnostic and interventional applications of GI endoscopy. Healthcare policies and physician awareness continue to evolve in the region, favoring procedure volume growth for GI endoscopy.

This Medtech 360 Report provides high-level market metrics for GI endoscopy devices in Latin America, including country-level data for major countries and aggregate data for the rest of the Latin American region from 2019 through 2032.

Table of contents


Related Medtech Insights Reports

Report
ENT Devices – Market Insights – United States
The US ENT device market will grow modestly over the forecast period, with the nasal packing and myringotomy/tympanostomy device segments seeing the fastest growth rates. The market will be…
Report
Gastrointestinal Endoscopy Devices – Market Insights – United States
The US GI endoscopy device market is projected to experience modest expansion through 2034. The market growth is being driven by supportive treatment and screening guidelines, the growing use of AI…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Asia Pacific
The GI endoscopy device market will continue to grow moderately throughout the forecast period, supported by the high incidence of gastric cancer and CRC cases in the region. Growth will be…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…